ARCHIVES

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

This article is from The Cancer Letter archive.

Vol. 24 No. 10 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

RFA/PA/Drug Group Announcement Limited

May 6, 1988

Jackson Lab Should Be Rebuilt With Federal Funds, Panel Says

September 29, 1989

Allegations Reflect Misunderstanding, Pan Data Says

August 4, 1989

Baltimore Reports On New Method To Aid Leukemia Therapy Design

May 20, 1977

In Brief: Appropriations Markup Delayed Until September; FCRC Recompetition Draws 94 Requests for RFP

July 31, 1981

Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers

April 25, 1980